Haematologica, Vol 92, Issue 12, 1723-1724 doi:10.3324/haematol.11525
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuster, J. L.
Right arrow Articles by Ortuño, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuster, J. L.
Right arrow Articles by Ortuño, F. J.

Acute Lymphoblastic Leukemia

Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia

José Luis Fuster*,, Mar Bermúdez*, Ana Galera*, María Esther Llinares*, Doris Calle°, Francisco Jose Ortuño#

* Hospital Universitario Virgen de la Arrixaca, Murcia, Spain;
° Clínica Solca, Guayaquil, Ecuador;
# Hospital Morales Meseguer, Murcia, Spain

Correspondence: Jose Luis Fuster, Unidad de Oncohematología Pediátrica, Hospital Universitario Virgen de la Arrixaca, Ctra. Madrid-Cartagena s/n, El Palmar, 30120, Murcia, Spain. Phone: international +34.968369082/34.968369297. Fax: international +34.968369077. E-mail: josel.fuster{at}carm.es

The role of imatinib in childhood Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) has not been established. We treated four children with imatinib in combination with conventional chemotherapy (CT) before stem cell transplantation (SCT). Response evaluation consisted of fluorocytometric analysis of minimal residual disease (MRD) and standard qualitative RT-PCR follow-up.

Key words: Philadelphia chromosome, ALL, childhood, imatinib, chemotherapy.




This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
A. S. Wayne, G. H. Reaman, and L. J. Helman
Progress in the Curative Treatment of Childhood Hematologic Malignancies
J Natl Cancer Inst, September 17, 2008; 100(18): 1271 - 1273.
[Full Text] [PDF]